GE HealthCare Adds AI Lung and Heart Tools to Vscan Air
The updates bring real-time lung guidance and aortic stenosis screening to the handheld ultrasound system.
Updated on Nov. 3, 2026 in Asthma
GE HealthCare introduced Lung Guidance and AutoAS AI tools for its Vscan Air handheld ultrasound system. Existing customers with a valid Innovation Package subscription or license are expected to receive the updates by the end of November.
Why it matters
Handheld ultrasound with built-in AI guidance may let clinicians with varying levels of experience acquire usable scans and flag possible heart valve disease. Both tools have received U.S. FDA 510(k) clearance and carry the CE Mark.
In validation testing, nonexpert users acquired diagnostic-quality lung exams 95.2% of the time, compared with 96.8% for expert users. The tools' real-world clinical outcomes are not described in the available extraction.
The players
GE HealthCare
A global medical technology company that develops imaging, ultrasound and patient-monitoring equipment used in hospitals and clinics worldwide.
U.S. Food and Drug Administration (FDA)
The U.S. federal agency responsible for regulating medical devices, which granted 510(k) clearance to both tools.
The details
Lung Guidance corrects anatomical landmarks in real time across the standard eight-zone lung protocol and automatically captures clips when image-quality criteria are met, including B-line detection and scoring. AutoAS analyzes at least two standard 2D echocardiographic views acquired with Vscan Air SL and indicates whether findings suggest moderate-to-severe aortic stenosis, with a confidence score.
Timeline
November 3, 2026: GE HealthCare announces Lung Guidance and AutoAS tools for Vscan Air.
End of November 2026: Existing Vscan Air customers with a valid Innovation Package subscription or license are expected to receive the updates.
Roadmap
The update extends the Vscan Air handheld platform by layering AI-guided lung and aortic stenosis analysis onto devices already in clinical use. It reflects a broader push to bring specialist-level imaging workflows to point-of-care settings.
Clinicians using Vscan Air may gain AI guidance for lung scans and a screening flag for aortic stenosis at the point of care. The update reaches existing subscribers without a new device purchase, according to the announcement.
The takeaway
Point-of-care ultrasound with AI guidance can narrow the skill gap between nonexpert and expert operators. Clinicians should still rely on established diagnostic pathways when interpreting these screening outputs.
What happens next
Existing Vscan Air customers with a valid Innovation Package subscription or license are expected to receive the updates by the end of November 2026.
Further reading
For more on lung conditions that these lung-imaging tools may help assess, see Asthma.
